Sepsis And Septic Shock Treatment Market

Market Insights

Sepsis is a potentially life-threatening complication due to infection and the systemic inflammatory response; an overwhelming immune response to infection causes it. Sepsis is treated as a medical emergency, and a severe case of sepsis may lead to septic shock, in which blood pressure reduces dramatically. It is estimated that the sepsis and septic shock treatment market will show significant market growth over the forecast period, primarily due to the growing number of target populations, a higher number of unmet needs, advancements in sepsis assessment techniques, and the presence of novel pipeline therapeutics.

The “Sepsis and Septic Shock Treatment Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” included an in-depth analysis of the sepsis and septic shock market from 2015 to 2025. This market report includes a detailed study of market segments based on treatment types such as antimicrobial therapy (antibacterial drugs, antiviral drugs, and antifungal drugs) and adjunctive therapy (mechanical ventilation, vasopressor therapy, fluid therapy, corticosteroids, blood transfusion, dialysis, and insulin therapy).

For the geographical study, the global sepsis and septic shock treatment market is categorized based on key regional markets such as North America, Europe, Latin America, Asia Pacific, the Middle East, and Africa. For further regional and country-level analysis, the sepsis and septic shock treatment market is categorized into the United States, Canada, Germany, the United Kingdom, and the rest of Europe, as well as Brazil, Mexico, the rest of LATAM, China, Japan, the rest of APAC, the GCC, and the rest of MEA.

Along with statistical information, in-depth qualitative information assessment tools are included in this study to better understand the general market situation and future prospects. For an understanding of ongoing trends in the market and a future market scenario, detailed information regarding pipeline analysis, market drivers, challenges, and opportunities in the global sepsis and septic shock treatment market is included in the report. In addition, an attractive investment proposition and company profiling section are also included in this report to provide in-depth information about the key players involved in sepsis and septic shock R&D activities.

Based on treatment types, the global sepsis and septic shock treatment market is segmented as follows:

• Antimicrobial Therapy
• Antibacterial Drugs
• Cephalosporins
• Macrolides
• Aminoglycosides
• Penicillins
• Lincosamides
• Quinolones
• Sulfonamides
• Glycopeptides
• Other
• Antiviral Drugs
• Antifungal Drugs
• Adjunctive Therapy
• Mechanical ventilation
• Vasopressor therapy
• Fluid Therapy
• Corticosteroids
• Blood transfusion
• Dialysis
• Insulin Therapy

It is expected that the global sepsis and septic shock treatment market will show lucrative market growth, primarily due to the rising number of the affected population, technological development in sepsis assessment, an increase in research and development for developing sepsis treatments, and the expected launch of novel pipeline molecules over the forecast period. According to research, antibacterial drugs are the most profitable antimicrobial therapy segment and are expected to grow at the fastest rate during the forecast period. Because bacteria such as Staphylococcus and Escherichia coli are the most common causes of sepsis, Furthermore, the expected launch of pipeline drugs such as MDX-1105, CYT-107, ALT-836, LB-1148, IFX-1, etc., would assist the market growth of sepsis drugs during the forecast period. Broad-spectrum antibiotics are preferably used to initiate treatment as these are effective against a variety of bacteria. Currently, there is no approved regimen specific to treating sepsis, but antimicrobials and adjunctive therapies are used to treat and manage sepsis. Previously, activated drotrecogin alfa (Xigris) was approved for sepsis but was voluntarily withdrawn by Eli Lilly in 2011 due to a lack of efficacy.

For this study, the global sepsis and septic shock treatment market is categorized into

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Russia
  • Rest of Europe
• Asia-Pacific
  • India
  • China
  • Japan
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Sepsis is a clinical condition caused by an excessive inflammatory response to infection, which results in multiple organ dysfunction. According to the Centers for Disease Control and Prevention (CDC), more than 1.5 million people are affected by sepsis in the United States; 250,000 Americans die every year. It is observed that among the considered geographical markets, North America currently dominates the global sepsis and septic shock treatment market, and the United States mainly drives the growth. Early diagnosis of the disease, availability of developed techniques for sepsis assessment, wide accessibility to therapeutics, favorable government reimbursement policies, higher cost of therapeutics, and a well-developed healthcare infrastructure are the essential factors that favor the market dominance of North America. On the other hand, the sepsis and septic shock treatment market in the Asia Pacific will show the fastest market growth over the forecast period due to developing healthcare infrastructure, the rising number of the affected population, and the increasing penetration of key players in emerging countries such as China and India.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Sepsis and Septic Shock Treatment Market Portraiture
2.1.1. Global Sepsis and Septic Shock Treatment Market, by Treatment Type, 2016
2.1.2. Global Sepsis and Septic Shock Treatment Market, by Geography, 2016

Chapter 3. Sepsis and Septic Shock Treatment: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography, 2016
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Pipeline Analysis of Sepsis and Septic Shock Treatment Drugs
4.1. Overview
4.2. Tabular Representation of Sepsis and Septic Shock Pipeline Drugs

Chapter 5. Global Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Antimicrobial Therapy
5.2.1. Antibacterial Drugs
5.2.1.1. Cephalosporins
5.2.1.2. Macrolides
5.2.1.3. Aminoglycosides
5.2.1.4. Penicillins
5.2.1.5. Lincosamides
5.2.1.6. Quinolones
5.2.1.7. Sulfonamides
5.2.1.8. Glycopeptides
5.2.1.9. Other
5.2.2. Antiviral Drugs
5.2.3. Antifungal Drugs
5.3. Adjunctive Therapy
5.3.1. Mechanical ventilation
5.3.2. Vasopressor therapy
5.3.3. Fluid Therapy
5.3.4. Corticosteroids
5.3.5. Blood transfusion
5.3.6. Dialysis
5.3.7. Insulin Therapy

Chapter 6. Global Sepsis and Septic Shock Treatment Market, by Geography, 2015 – 2025
6.1. Overview
6.2. North America Sepsis and Septic Shock Treatment Market Analysis, 2015 – 2025
6.2.1. North America Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
6.2.2. North America Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
6.2.2.1. U.S.
6.2.2.2. Canada
6.3. Europe Sepsis and Septic Shock Treatment Market Analysis, 2015 – 2025
6.3.1. Europe Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
6.3.2. Europe Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
6.3.2.1. U.K.
6.3.2.2. Germany
6.3.2.3. Rest of Europe
6.4. Asia Pacific Sepsis and Septic Shock Treatment Market Analysis , 2015 – 2025
6.4.1. Asia Pacific Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
6.4.2.1. China
6.4.2.2. Japan
6.4.2.3. Rest of APAC
6.5. Latin America Sepsis and Septic Shock Treatment Market Analysis , 2015 – 2025
6.5.1. Latin America Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
6.5.2.1. Brazil
6.5.2.2. Mexico
6.5.2.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Sepsis and Septic Shock Treatment Market Analysis, 2015 – 2025
6.6.1. MEA Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
6.6.2. MEA Sepsis and Septic Shock Treatment Market, by Region, 2015 – 2025 (US$ Mn)
6.6.2.1. GCC
6.6.2.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Adrenomed AG
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Treatment Type Portfolio
7.1.4. Key Developments
7.2. Altor BioScience Corporation
7.3. Asahi Kasei Pharma
7.4. Boehringer Ingelheim GmbH
7.5. Bristol-Myers Squibb
7.6. InflaRx GmbH
7.7. Inotrem SA
7.8. Pfizer Inc.
7.9. Other Notable Players

List of Figures

FIG. 1 Sepsis and Septic Shock Treatment: Market Segmentation
FIG. 2 Global Sepsis and Septic Shock Treatment Market, by Treatment Type, 2016 (US$ Mn)
FIG. 3 Global Sepsis and Septic Shock Treatment Market, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography
FIG. 5 Market Competition Landscape, by Key Players, 2016
FIG. 6 Global Cephalosporins Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 7 Global Macrolides Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 8 Global Aminoglycosides Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 9 Global Penicillins Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 10 Global Lincosamides Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 11 Global Quinolones Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 12 Global Sulfonamides Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 13 Global Glycopeptides Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 14 Global Other Antibacterial Drugs Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 15 Global Antiviral Drugs Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 16 Global Antifungal Drugs Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 17 Global Mechanical ventilation Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 18 Global Vasopressor therapy Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 19 Global Fluid Therapy Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 20 Global Corticosteroids Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 21 Global Blood Transfusion Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 22 Global Dialysis Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 23 Global Insulin Therapy Market for Sepsis and Septic Shock Treatment, 2015 – 2025 (US$ Mn)
FIG. 24 U.S. Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 25 Canada Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 26 U.K. Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 27 Germany Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 28 Rest of Europe Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 29 Japan Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 30 China Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 31 Rest of Asia Pacific Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 32 Brazil Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 33 Mexico Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 34 Rest of Latin America Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 35 GCC Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)
FIG. 36 Rest of Middle East and Africa Sepsis and Septic Shock Treatment Market, 2015 – 2025 (US$ Mn)

List of Tables

TABLE 1 Global Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)

TABLE 2 Global Antimicrobial Therapy Market for Sepsis and Septic Shock Treatment, by Drug Class, 2015 – 2025 (US$ Mn)
TABLE 3 Global Antibacterial Therapy Market for Sepsis and Septic Shock Treatment, by Drug Class, 2015 – 2025 (US$ Mn)
TABLE 4 North America Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 5 North America Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 7 Europe Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 8 Asia Pacific Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 9 Asia Pacific Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 10 Latin America Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 11 Latin America Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 12 Middle East and Africa Sepsis and Septic Shock Treatment Market, by Treatment Type, 2015 – 2025 (US$ Mn)
TABLE 13 Middle East and Africa Sepsis and Septic Shock Treatment Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 14 Adrenomed AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 15 Altor BioScience Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 16 Asahi Kasei Pharma: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 Boehringer Ingelheim GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 Bristol-Myers Squibb: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 InflaRx GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Inotrem SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)